These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34143886)

  • 1. Prognostic Implications of Preablation Stimulated Tg: A Retrospective Analysis of 2500 Thyroid Cancer Patients.
    Tian T; Xu Y; Zhang X; Liu B
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4688-e4697. PubMed ID: 34143886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Pre-Ablation Stimulated Thyroglobulin in Children and Adolescents with Differentiated Thyroid Cancer.
    Liu L; Zhang X; Tian T; Huang R; Liu B
    Thyroid; 2020 Jul; 30(7):1017-1024. PubMed ID: 31964278
    [No Abstract]   [Full Text] [Related]  

  • 3. PRE-ABLATION THYROGLOBULIN AND THYROGLOBULIN TO THYROID-STIMULATING HORMONE RATIO MAY BE ASSOCIATED WITH PULMONARY METASTASES IN CHILDREN WITH DIFFERENTIATED THYROID CANCER.
    Livhits MJ; Pasternak JD; Xiong M; Li N; Gosnell JE; Yeh MW; Chiu HK
    Endocr Pract; 2016 Nov; 22(11):1259-1266. PubMed ID: 27482611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of postoperative stimulated thyroglobulin level at the time of 131I ablation therapy for differentiated thyroid cancer.
    Hasbek Z; Turgut B; Kilicli F; Altuntas EE; Yucel B
    Asian Pac J Cancer Prev; 2014; 15(6):2523-7. PubMed ID: 24761858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation size of lymph node metastasis focus and pre-ablation stimulated Tg could more effectively predict clinical outcomes in differentiated thyroid cancer patients without distant metastases.
    Xie J; Chen P; Wang J; Luo X; Luo J; Xiong X; Li C; Pan L; Wu J; Feng H; Ouyang W
    Front Endocrinol (Lausanne); 2023; 14():1094339. PubMed ID: 37025409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of initial stimulation thyroglobulins and staging system by revised ATA guidelines can elaborately discriminate prognosis of patients with differentiated thyroid carcinoma after high-dose remnant ablation.
    Kim MH; Ko SH; Bae JS; Lim DJ; Baek KH; Lee JM; Kang MI; Cha BY
    Clin Nucl Med; 2012 Nov; 37(11):1069-74. PubMed ID: 22996253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of post-ablation stimulated thyroglobulin in differentiated thyroid cancer patients with biochemical incomplete response: a bi-center observational study.
    Wang Y; Wu J; Jiang L; Zhang X; Liu B
    Endocrine; 2022 Apr; 76(1):109-115. PubMed ID: 35094313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age, thyroglobulin levels and ATA risk stratification predict 10-year survival rate of differentiated thyroid cancer patients.
    Kelly A; Barres B; Kwiatkowski F; Batisse-Lignier M; Aubert B; Valla C; Somda F; Cachin F; Tauveron I; Maqdasy S
    PLoS One; 2019; 14(8):e0221298. PubMed ID: 31425569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of serum thyroglobulin measurement at the time of remnant ablation for predicting disease-free status in patients with differentiated thyroid cancer: a meta-analysis involving 3947 patients.
    Webb RC; Howard RS; Stojadinovic A; Gaitonde DY; Wallace MK; Ahmed J; Burch HB
    J Clin Endocrinol Metab; 2012 Aug; 97(8):2754-63. PubMed ID: 22639291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preablative Stimulated Thyroglobulin Correlates to New Therapy Response System in Differentiated Thyroid Cancer.
    Yang X; Liang J; Li T; Zhao T; Lin Y
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1307-13. PubMed ID: 26789779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictive value for excellent response to initial therapy in differentiated thyroid cancer: preablation-stimulated thyroglobulin better than the TNM stage.
    Zhang Y; Hua W; Zhang X; Peng J; Liang J; Gao Z
    Nucl Med Commun; 2018 May; 39(5):405-410. PubMed ID: 29557849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influencing Factors of Urinary Iodine Concentration Before and After Radioiodine Therapy for Differentiated Thyroid Cancer: An Initial Exploration of the Relationship With Therapeutic Efficacy.
    Liu Q; Zhou H; Xia Y; Huang Y; Liu L; Jiang X; Shi Y
    Cancer Control; 2024; 31():10732748241292786. PubMed ID: 39405376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative stimulated thyroglobulin level and recurrence risk stratification in differentiated thyroid cancer.
    Yang X; Liang J; Li TJ; Yang K; Liang DQ; Yu Z; Lin YS
    Chin Med J (Engl); 2015 Apr; 128(8):1058-64. PubMed ID: 25881600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulated Thyroglobulin and Thyroglobulin Reduction Index Predict Excellent Response in Differentiated Thyroid Cancers.
    Barres B; Kelly A; Kwiatkowski F; Batisse-Lignier M; Fouilhoux G; Aubert B; Dutheil F; Tauveron I; Cachin F; Maqdasy S
    J Clin Endocrinol Metab; 2019 Aug; 104(8):3462-3472. PubMed ID: 30785995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative-stimulated serum thyroglobulin measured at the time of 131I ablation is useful for the prediction of disease status in patients with differentiated thyroid carcinoma.
    Lee JI; Chung YJ; Cho BY; Chong S; Seok JW; Park SJ
    Surgery; 2013 Jun; 153(6):828-35. PubMed ID: 23489940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.
    Lima N; Cavaliere H; Tomimori E; Knobel M; Medeiros-Neto G
    J Endocrinol Invest; 2002 Feb; 25(2):110-5. PubMed ID: 11929080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of FDG PET/CT on the follow-up of patients of differentiated thyroid carcinoma with negative 131I whole-body scan and elevated thyroglobulin levels: correlation with clinical and histopathologic characteristics and long-term follow-up data.
    Vural GU; Akkas BE; Ercakmak N; Basu S; Alavi A
    Clin Nucl Med; 2012 Oct; 37(10):953-9. PubMed ID: 22899202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of preablation stimulated thyroglobulin and thyroglobulin/thyroid-stimulating hormone ratio in differentiated thyroid cancer.
    Lin Y; Li T; Liang J; Li X; Qiu L; Wang S; Chen Y; Kang Z; Li F
    Clin Nucl Med; 2011 Dec; 36(12):1102-5. PubMed ID: 22064080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of postoperative anti-thyroglobulin antibody in patients with differentiated thyroid cancer.
    Zhao Y; Mu Z; Liang D; Zhang T; Zhang X; Sun D; Sun Y; Liang J; Lin Y
    Front Endocrinol (Lausanne); 2024; 15():1354426. PubMed ID: 38721144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sufficiency of a Single Negative Thyroglobulin Standard for Judging the Success of Ablation in Low- and Intermediate-risk Differentiated Thyroid Cancer: A Retrospective Study.
    Long Y; Jin J; Zhang W
    Endocr Metab Immune Disord Drug Targets; 2024; 24(10):1204-1214. PubMed ID: 38192150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.